Tech Company Financing Transactions

Axonics Modulation Technologies Funding Round

On 5/3/2017, Axonics Modulation Technologies raised $14.5 million in Series C investment from Advent Life Sciences, Cormorant Asset Management and Edmond de Rothschild Investment Partners.

Transaction Overview

Company Name
Axonics Modulation Technologies
Announced On
5/3/2017
Transaction Type
Venture Equity
Amount
$14,500,000
Round
Series C
Investors

Advent Life Sciences (Shahzad Malik)

Cormorant Asset Management

Edmond de Rothschild Investment Partners (Raphaël Wisniewski)

Legend Capital (Darren Cai)

NeoMed Management (Erik Amble)

Proceeds Purpose
Proceeds from the financing will be used to conduct a pivotal clinical study in Overactive Bladder patients to gain U.S. FDA approval and prepare the Company to access markets around the world.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
26 Technology Dr.
Irvine, CA 92618
USA
Phone
(949) 396-6322
Website
www.axonicsmodulation.com
Email Address
Not Recorded
Overview
Axonics, based in Irvine, Calif., is a privately held venture-backed pre-revenue company developing novel implantable neuromodulation devices.
Profile
Axonics Modulation Technologies LinkedIn Company Profile
Social Media
Axonics Modulation Technologies Company Twitter Account
Company News
Axonics Modulation Technologies News
Facebook
Axonics Modulation Technologies on Facebook
YouTube
Axonics Modulation Technologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Raymond Cohen
  Raymond Cohen LinkedIn Profile  Raymond Cohen Twitter Account  Raymond Cohen News  Raymond Cohen on Facebook
Chief Medical Officer
Karen Noblett
  Karen Noblett LinkedIn Profile  Karen Noblett Twitter Account  Karen Noblett News  Karen Noblett on Facebook
Chief Operating Officer
Daniel Dearen
  Daniel Dearen LinkedIn Profile  Daniel Dearen Twitter Account  Daniel Dearen News  Daniel Dearen on Facebook
Chief Technical Officer
Guangqiang Jiang
  Guangqiang Jiang LinkedIn Profile  Guangqiang Jiang Twitter Account  Guangqiang Jiang News  Guangqiang Jiang on Facebook
VP - Bus. Development
Emilie Finiels
  Emilie Finiels LinkedIn Profile  Emilie Finiels Twitter Account  Emilie Finiels News  Emilie Finiels on Facebook
VP - General Counsel
Michael Williamson
  Michael Williamson LinkedIn Profile  Michael Williamson Twitter Account  Michael Williamson News  Michael Williamson on Facebook
VP - Marketing
John Woock
  John Woock LinkedIn Profile  John Woock Twitter Account  John Woock News  John Woock on Facebook
VP - Operations
Rinda Sama
  Rinda Sama LinkedIn Profile  Rinda Sama Twitter Account  Rinda Sama News  Rinda Sama on Facebook
VP - Product Management
Prabodh Mathur
  Prabodh Mathur LinkedIn Profile  Prabodh Mathur Twitter Account  Prabodh Mathur News  Prabodh Mathur on Facebook

 

 

Browse more venture capital transactions:

Prev: 5/3/2017: PreparedHealth venture capital transaction
Next: 5/3/2017: CreatorIQ venture capital transaction

 

Share this article

 

About Database of VC Transactions

We record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.